AnvilCore Research
CJC-1295 w/o DAC research material is available in 2 formats. Select a tab to review the available strength.
Technical research description
CJC-1295 without DAC is the common research-market name for a shorter-acting, modified GHRH(1-29) analogue. It is studied as a ligand of the pituitary GHRH receptor and as a tool for examining pulsatile growth-hormone signaling without the albumin-binding DAC extension.
CJC-1295 without DAC is the common research-market name for a shorter-acting, modified GHRH(1-29) analogue. It is studied as a ligand of the pituitary GHRH receptor and as a tool for examining pulsatile growth-hormone signaling without the albumin-binding DAC extension.
Amino-acid sequence
Tyr — D-Ala — Asp — Ala — Ile — Phe — Thr — Gln — Ser — Tyr — Arg — Lys — Val — Leu — Ala — Gln — Leu — Ser — Ala — Arg — Lys — Leu — Leu — Gln — Asp — Ile — Leu — Ser — Arg — NH₂
Modified GRF(1–29) sequence without the DAC group.
CJC-1295 w/o DAC — 5 mg
- Strength
- 5 mg
- Format
- Powder
- Retail price (USD)
- $26.00
Adds CJC-1295 w/o DAC — 5 mg to your cart. Research and laboratory use only.
CJC-1295 w/o DAC — 10 mg
- Strength
- 10 mg
- Format
- Powder
- Retail price (USD)
- $41.60
Adds CJC-1295 w/o DAC — 10 mg to your cart. Research and laboratory use only.
Research use only. Not for human consumption or clinical, diagnostic, or therapeutic use.